About

CORPORATE PROFILE

GI Dynamics, Inc. (ASX: GID) is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and/or obesity... Read more...
ASX : GID.AX (CHESS Depository Interests)
A$0.03 - 0.01
Stock chart for: GID.AX.  Currently trading at A$0.03 with a 52 week high of A$0.04 and a 52 week low of A$0.02.
Aug 26, 2016 4:10 p.m.
AUS EST
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
RECENT NEWSView All
Jul-28-2016

GI Dynamics, Inc.: Appendix 4C: Quarter ended 30 June 2016

Investor Call to Discuss Quarterly Results and Update on Strategy, Data and Cash Flow 6:30 p

Read More

Jul-27-2016

Appendix 4C: Quarter ended 30 June 2016

Read More

UPCOMING EVENTSView All
Thursday, September 8, 2016 - Sunday, September 11, 2016

American Society of Gastroenterology (ASG)

Friday, September 9, 2016 - Saturday, September 10, 2016

Federation of Euro Nurses in Diabetes

INVESTOR CONTACT

Main:
  investor@gidynamics.com
781-357-3250 (U.S.)

U.S./Europe:
  investor@gidynamics.com
+1 781-357-3250 (U.S.)

Australia:
David Allen or John Granger
Hawkesbury Partners Pty Limited
  dallen@hawkesburypartners.com
  jgranger@hawkesburypartners.com
+61 2 9325 9046

SHARE REGISTRY

Link Market Services Limited
General Shareholder Enquiries:
Phone: 1300 554 474 (toll free) or +61 2 8280 7111
  registrars@linkmarketservices.com.au
Fax: +61 2 9287 0303
Online investor log-in
  Locked Bag A14
    Sydney South NSW 1235
    Australia

Quote is a for a CHESS Depositary Interests (CDI)
1 share of common stock = 50 CDIs